Keywords: eisai, abbott, japan, sign, deal, over, anti-rheumatic

Eisai and Abbott Japan sign deal over anti-rheumatic D2E7

Article | 18 April 2005

Print This

Japanese drugmaker Eisai and Abbott Japan, a subsidiary of the USA's Abbott Laboratories, have signed a development agreement for the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in